Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Gilbert Youssef"'
Autor:
Sebastian M. Christ, Gilbert Youssef, Shyam K. Tanguturi, Daniel Cagney, Diana Shi, J. Ricardo McFaline-Figueroa, Ugonma Chukwueke, Eudocia Q. Lee, Caroline Hertler, Nicolaus Andratschke, Michael Weller, David A. Reardon, Daphne Haas-Kogan, Matthias Guckenberger, Patrick Y. Wen, Rifaquat Rahman
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 44, Iss , Pp 100697- (2024)
Introduction and background: While recurrent glioblastoma patients are often treated with re-irradiation, there is limited data on the use of re-irradiation in the setting of bevacizumab (BEV), temozolomide (TMZ) re-challenge, or immune checkpoint in
Externí odkaz:
https://doaj.org/article/25491ed7bda84b609fc4d99318463fa8
Autor:
Gilbert Youssef, Patrick Y Wen
Publikováno v:
Glioma, Vol 3, Iss 2, Pp 31-33 (2020)
Externí odkaz:
https://doaj.org/article/6e1c3ce7935741c6a57b5b342a824473
Autor:
Gilbert Youssef, Rifaquat Rahman, Camden Bay, Wei Wang, Mary Jane Lim-Fat, Omar Arnaout, Wenya Linda Bi, Daniel N. Cagney, Yuh-Shin Chang, Timothy F. Cloughesy, Matthew DeSalvo, Benjamin M. Ellingson, Thomas F. Flood, Elizabeth R. Gerstner, L. Nicolas Gonzalez Castro, Jeffrey P. Guenette, Albert E. Kim, Eudocia Q. Lee, Jose R. McFaline-Figueroa, Christopher A. Potter, David A. Reardon, Raymond Y. Huang, Patrick Y. Wen
Publikováno v:
Journal of Clinical Oncology.
PURPOSE The Response Assessment in Neuro-Oncology (RANO) criteria are widely used in high-grade glioma clinical trials. We compared the RANO criteria with updated modifications (modified RANO [mRANO] and immunotherapy RANO [iRANO] criteria) in patien
Autor:
Benjamin M Ellingson, Patrick Y Wen, Susan M Chang, Martin van den Bent, Michael A Vogelbaum, Gang Li, Shanpeng Li, Jiyoon Kim, Gilbert Youssef, Wolfgang Wick, Andrew B Lassman, Mark R Gilbert, John F de Groot, Michael Weller, Evanthia Galanis, Timothy F Cloughesy
Publikováno v:
Neuro-Oncology, 25(6), 1017-1028. Oxford University Press
Durable objective response rate (ORR) remains a meaningful endpoint in recurrent cancer; however, the target ORR for single-arm recurrent glioblastoma trials has not been based on historic information or tied to patient outcomes. The current study re
Autor:
Benjamin M, Ellingson, Patrick Y, Wen, Susan M, Chang, Martin, van den Bent, Michael A, Vogelbaum, Gang, Li, Shanpeng, Li, Jiyoon, Kim, Gilbert, Youssef, Wolfgang, Wick, Andrew B, Lassman, Mark R, Gilbert, John F, de Groot, Michael, Weller, Evanthia, Galanis, Timothy F, Cloughesy
Publikováno v:
Neuro-oncology.
Durable objective response rate (ORR) remains a meaningful endpoint in recurrent cancer; however, the target ORR for single arm recurrent glioblastoma trials has not been based on historic information or tied to patient outcomes. The current study re
Autor:
Benjamin Ellingson, Patrick Y Wen, Susan Chang, Martin van den Bent, Michael Vogelbaum, Gang Li, Shanpeng Li, Jiyoon Kim, Gilbert Youssef, Wolfgang Wick, Andrew Lassman, Mark Gilbert, John de Groot, Michael Weller, Evanthia Galanis, Timothy Cloughesy
Publikováno v:
Neuro-Oncology. 24:vii172-vii173
Durable overall response rate (ORR) remains a meaningful endpoint in recurrent GBM; however, the target ORR for single arm recurrent GBM trials has not been based on historic information or tied to patient outcomes. The current study reviewed past tr
Autor:
Jamie A Dean, Shyam K Tanguturi, Daniel Cagney, Kee-Young Shin, Gilbert Youssef, Ayal Aizer, Rifaquat Rahman, Lubna Hammoudeh, David Reardon, Eudocia Lee, Jorg Dietrich, Kaoru Tamura, Masaru Aoyagi, Lacey Wickersham, Patrick Y Wen, Paul Catalano, Daphne Haas-Kogan, Brian M Alexander, Franziska Michor
Publikováno v:
Neuro-oncology.
Background Glioblastomas comprise heterogeneous cell populations with dynamic, bidirectional plasticity between treatment-resistant stem-like and treatment-sensitive differentiated states, with treatment influencing this process. However, current tre
Autor:
Manmeet S. Ahluwalia, Yesne Alici, Deborah Allen, Brian M. Andersen, Joachim M. Baehring, Onyinye Balogun, Taylor Beal, Richard Douglas Beegle, Ankush Bhatia, Rachel Boutte, Priscilla K. Brastianos, Julia Brechbeil, William S. Breitbart, Toni Cao, Alan Carver, Marc C. Chamberlain, Samuel T. Chao, Eloise Chapman-Davis, Zhi-Jian Chen, Nathan Cherny, Ashish Dahal, Mark A. Damante, Annick Desjardins, Karan S. Dixit, Sean Dodson, J. Bradley Elder, Marc S. Ernstoff, Camilo E. Fadul, Shannon Fortin Ensign, Ashley Ghiaseddin, Sarah Goldberg, David Gritsch, Craig Horbinski, Jana Ivanidze, Larry Junck, Jeffrey M. Katz, Leon D. Kaulen, Moh'd Khushman, Cassie Kline, Priya Kumthekar, Mark Kurzrok, Autumn Lanoye, Juliana Larson, Eudocia Q. Lee, Denise Leung, Angela Liou, Simon S. Lo, Ashlee R. Loughan, Benjamin Lu, Rimas V. Lukas, Mark G. Malkin, Jacob Mandel, Kaitlyn Melnick, Jennifer Moliterno, Maciej M. Mrugala, Sabine Mueller, Erin S. Murphy, John Vincent Murray, Herbert B. Newton, Evan K. Noch, Barbara J. O’Brien, Patrick O’Shea, Eseosa Odigie, Alexander C. Ou, Nina A. Paleologos, Susan C. Pannullo, Kester A. Phillips, Alberto Picca, Alyx B. Porter, Amy A. Pruitt, Dimitri Psimaras, Yasmeen Rauf, Scott Ravyts, David A. Reardon, Varalakshmi Ballur Narayana Reddy, Morgan Reid, Maricruz Rivera, Anthony Rosenberg, Amber Nicole Ruiz, Magali de Sauvage, Shreya Saxena, David Schiff, David Shin, Seema Shroff, Karanvir Singh, Mohini Singh, Prathusan Subramaniam, John H. Suh, Ashley L. Sumrall, Lynne P. Taylor, Jigisha P. Thakkar, Joshua L. Wang, Patrick Y. Wen, Timothy G. White, Kelcie Willis, Jean-Paul Wolinsky, Kailin Yang, Lalanthica V. Yogendran, Gilbert Youssef, Michael N. Youssef, Zhen Ni Zhou, Alicia M. Zukas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17ca7d9f31ae8eb071484718149186e8
https://doi.org/10.1016/b978-0-12-821976-8.09988-6
https://doi.org/10.1016/b978-0-12-821976-8.09988-6
Autor:
Mary Jane Lim-Fat, Daniel N. Cagney, L. Nicolas Gonzalez Castro, David A. Reardon, Rifaquat Rahman, Omar Arnaout, Matthew N. DeSalvo, Christopher A. Potter, Eudocia Q. Lee, Gilbert Youssef, Wenya Linda Bi, J Ricardo McFaline-Figueroa, Timothy F. Cloughesy, Camden P. Bay, Jeffrey P. Guenette, Raymond Y. Huang, Patrick Y. Wen, Benjamin M. Ellingson
Publikováno v:
Neuro Oncol
BACKGROUND Accurate response criteria are crucial for determining treatment efficacy. The response assessment in neuro-oncology (RANO) criteria was developed to standardize response assessment in neuro-oncology. Modified RANO (m-RANO) criteria were r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42a56ec641d76f21e84995c27ca2a94f
https://europepmc.org/articles/PMC8598494/
https://europepmc.org/articles/PMC8598494/